help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 15, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0319
A more recent version of this article appeared on February 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
22/2/388    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higgins, K. J.
Right arrow Articles by Safe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higgins, K. J.
Right arrow Articles by Safe, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL

Submitted on June 25, 2007
Accepted on November 5, 2007

Vascular Endothelial Growth Factor Receptor-2 Expression is Downregulated by 17{beta}-Estradiol in MCF-7 Breast Cancer Cells By Estrogen Receptor {alpha}/Sp Proteins

Kelly J. Higgins, Shengxi Liu, Maen Abdelrahim, Kathryn Vanderlaag, Xinyi Liu, Weston Porter, Richard Metz, and Stephen Safe*

Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843 (K.J.H., X.L., S.S.); Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX 77030 (S.L., M.A., S.S.); Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843 (K.V., S.S.); Department of Veterinary Integrated Biosciences, Texas A&M University, College Station, TX 77843 (W.P., R.M.)

* To whom correspondence should be addressed. E-mail: ssafe{at}cvm.tamu.edu.

17{beta}-Estradiol (E2) induces and represses gene expression in breast cancer cells; however, the mechanisms of gene repression are not well understood. In this study, we show that E2 decreases VEGFR2 mRNA levels in MCF-7 cells and this gene was used as a model for investigating pathways associated with E2-dependent gene repression. Deletion analysis of the VEGFR2 promoter indicates that the proximal GC-rich motifs at -58 and -44 are critical for the E2-dependent decreased response in MCF-7 cells. Mutation or deletion of these GC-rich elements results in loss of hormone-responsiveness and shows that the -60 to -37 region of the VEGFR2 promoter is critical for both basal and hormone-dependent decreased VEGFR2 expression in MCF-7 cells. Western-blot, immunofluorescent staining, RNA interference, and electrophoretic mobility shift assays support a role for Sp proteins in hormone-dependent downregulation of VEGFR2 in MCF-7 cells, primarily through ER{alpha}/Sp1 and ER{alpha}/Sp3 interactions with the VEGFR2 promoter. Using chromatin immunoprecipitation and transient transfection/RNA interference assays we show that the ER{alpha}/Sp protein-promoter interactions are accompanied by recruitment of the corepressors SMRT and NCoR to the promoter and that SMRT and NCoR knockdown reverse E2-mediated downregulation of VEGFR2 expression in MCF-7 cells. This study illustrates that both SMRT and NCoR are involved in E2-dependent repression of VEGFR2 in MCF-7 cells.


Key words: VEGFR2/KDR • induction • ERalpha/Sp

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα
Coregulators:   NCOR  |  SMRT
Ligands:   17β-Estradiol  |  Fulvestrant






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society